Exousia Pro, Inc., a clinical-stage biotech company that specializes in the use of exomes to treat cancer and other illnesses ...

The next time you go wild swimming, whether in a lake, river or sea, you are probably sharing the water with one of your ...

The award “recognises and encourages young scientists up to the age of 45 years who have made an exceptional contribution in ...

NovaBridge Biosciences (NovaBridge or the Company) today announced that it has changed its corporate name from ...

A gene that helped bowheads adapt to frigid Arctic waters also granted them extraordinary longevity. Could it help aging ...

iOrganBio today announced its launch from stealth with $2 million in funding to transform how human cells are made. The round was led by First Star Ventures along with institutional investors IndieBio ...

Avera’s expanded research programs let patients contribute to future cancer breakthroughs without traveling far ...

In Q1 FY26, cash receipts from customers were A$15k. The net cash used in G&A activities in the quarter was A$578k, compared to A$1.44 million in Q4 FY25. Payments to Related Parties comprises ...

I felt deeply uncomfortable with being sick, but in taking care of my scalp I learned to live with cancer in my own way.

It's been a heck of a year in academia. This podcast miniseries, in partnership with WNYC's On The Media, examines the moral calculus universities face in dealings with the Trump administration.

Black survivors of multiple myeloma say the latest developments in treatment give them hope even as federal research cuts ...

Organoids, three-dimensional cultures derived from stem cells, have rapidly emerged as a transformative technology within biomedical research. By closely ...